Cita APA (7a ed.)
Melhorn, P., Kretschmer-Chott, E., Mazal, P., Raderer, M., & Kiesewetter, B. (2025). Comparisons of treatment performance and therapy sequences in neuroendocrine neoplasms using progression-free survival ratios. European Journal of Nuclear Medicine & Molecular Imaging, 53(1), 263-275.
Cita Chicago Style (17a ed.)
Melhorn, Philipp, Elisabeth Kretschmer-Chott, Peter Mazal, Markus Raderer, y Barbara Kiesewetter. "Comparisons of Treatment Performance and Therapy Sequences in Neuroendocrine Neoplasms Using Progression-free Survival Ratios." European Journal of Nuclear Medicine & Molecular Imaging 53, no. 1 (2025): 263-275.
Cita MLA (9a ed.)
Melhorn, Philipp, et al. "Comparisons of Treatment Performance and Therapy Sequences in Neuroendocrine Neoplasms Using Progression-free Survival Ratios." European Journal of Nuclear Medicine & Molecular Imaging, vol. 53, no. 1, 2025, pp. 263-275.
Precaución: Estas citas no son 100% exactas.